CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Many symptoms of non-alcoholic fatty liver disease can be linked to comorbidities, such as obesity, which is the likely source of the reduction in cardiac output and CYP2E1 activity and expression seen in non-alcoholic fatty liver disease [42].